Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen

Mikrochim Acta. 2021 May 26;188(6):199. doi: 10.1007/s00604-021-04867-1.

Abstract

Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL-1 to 100 ng.mL-1 and a limit of detection of 0.4 pg.mL-1 for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection.

Keywords: Antibody; Biosensor; Electrochemical detection; Immunosensor; Nucleocapsid protein; Voltammetry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Immobilized / immunology
  • Biosensing Techniques / instrumentation
  • Biosensing Techniques / methods
  • COVID-19 / diagnosis*
  • COVID-19 Testing / instrumentation
  • COVID-19 Testing / methods*
  • Carbon / chemistry
  • Coronavirus Nucleocapsid Proteins / analysis*
  • Coronavirus Nucleocapsid Proteins / immunology
  • Electrochemical Techniques / instrumentation
  • Electrochemical Techniques / methods*
  • Electrodes
  • Fatty Acids / chemistry
  • Gold / chemistry
  • Humans
  • Immunoassay / instrumentation
  • Immunoassay / methods*
  • Limit of Detection
  • Metal Nanoparticles / chemistry
  • Nasopharynx / virology
  • Phosphoproteins / analysis
  • Phosphoproteins / immunology
  • SARS-CoV-2 / chemistry*
  • Sulfhydryl Compounds / chemistry

Substances

  • 11-mercaptoundecanoic acid
  • Antibodies, Immobilized
  • Coronavirus Nucleocapsid Proteins
  • Fatty Acids
  • Phosphoproteins
  • Sulfhydryl Compounds
  • nucleocapsid phosphoprotein, SARS-CoV-2
  • Carbon
  • Gold